SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-16-006230
Filing Date
2016-07-29
Accepted
2016-07-29 17:26:19
Documents
8
Period of Report
2016-07-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_072816.htm 8-K 29721
2 FORM OF WARRANT ex4-1.htm EX-4.1 83562
3 OPINION LETTER ex5-1.htm EX-5.1 10536
4 PLACEMENT AGENCY AGREEMENT ex10-1.htm EX-10.1 61137
5 FORM OF SECURITIES PURCHASE AGREEMENT ex10-2.htm EX-10.2 201449
6 PRESS RELEASE ex99-1.htm EX-99.1 10567
7 GRAPHIC ex5-1_img001.jpg GRAPHIC 63910
8 GRAPHIC ex5-1_img002.jpg GRAPHIC 73527
  Complete submission text file 0001387131-16-006230.txt   587297
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 161795101
SIC: 2834 Pharmaceutical Preparations